ArticleScientific data2025
A portable retina fundus photos dataset for clinical, demographic, and diabetic retinopathy prediction.
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Research advances on artificial intelligence assisted diagnosis and risk assessment in cardiovascular disease using retinal imaging.Frontiers in cardiovascular medicine · 2025Review
- A systematic review of vision and vision-language foundation models in ophthalmology.Advances in ophthalmology practice and researchReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper introduces mBRSET, the first publicly available diabetic retinopathy retina dataset captured using handheld retinal cameras in real-life, high-burden scenarios, comprising 5,164 images from 1,291 patients of diverse backgrounds. This dataset addresses the lack of ophthalmological data in low- and middle-income countries (LMICs) by providing a cost-effective and accessible solution for ocular screening and management. Portable retinal cameras enable applications outside traditional hospital settings, such as community health screenings and telemedicine consultations, thereby democratizing healthcare. Extensive metadata that are typically unavailable in other datasets, including age, sex, diabetes duration, treatments, and comorbidities, are also recorded. To validate the utility of mBRSET, state-of-the-art deep models, including ConvNeXt V2, Dino V2, and SwinV2, were trained for benchmarking, achieving high accuracy in clinical tasks diagnosing diabetic retinopathy, and macular edema; and in fairness tasks predicting education and insurance status. The mBRSET dataset serves as a resource for developing AI algorithms and investigating real-world applications, enhancing ophthalmological care in resource-constrained environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.